Description
Trametinib (GSK1120212) is a MEK inhibitor that inhibits MEK1 and MEK2 (IC50=0.7/0.9 nM) with ATP non-competitive and oral activity. Trametinib activates autophagy and induces apoptosis.
Molecular Formula
C26H23FIN5O4
Smiles
N(C1=C2C(N(C(=O)N(C2=O)C3CC3)C4=CC(NC(C)=O)=CC=C4)=C(C)C(=O)N1C)C5=C(F)C=C(I)C=C5
Storage
Powder: -20℃ for 3 years. In solvent: -80℃ for 1 year.
Solubility Information
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.1 mg/mL (3.41 mM), In vivo: Suspension. Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.DMSO: 7.86 mg/mL (12.77 mM)Ethanol: < 1 mg/mL (insoluble or slightly soluble)